Shi‐Ming Tu
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Oncology top 2%
- Bone health and treatments
Papers in
-
- Prostate Cancer Treatment and Research 22
- Sarcoma Diagnosis and Treatment 7
- Surgery 27
- Testicular diseases and treatments 18
- Bladder and Urothelial Cancer Treatments 7
- Co-authors
- Christopher J. Logothetis (27 shared papers)Lance C. Pagliaro (20 shared papers)Louis L. Pisters (22 shared papers)Danai Daliani (7 shared papers)Christos N. Papandreou (6 shared papers)Nizar M. Tannir (16 shared papers)Patricia Troncoso (8 shared papers)Randall E. Millikan (7 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Cancers (10 papers)Clinical Genitourinary Cancer (8 papers)Urologic Oncology Seminars and Original Investigations (6 papers)The Journal of Urology (5 papers)
- Partner nations
- United StatesSpainChina
In The Last Decade
Shi‐Ming Tu
91 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 100
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 1.1k
- Cancer Research 449
- Surgery 900
- Rheumatology 259
Countries citing papers authored by Shi‐Ming Tu
This map shows the geographic impact of Shi‐Ming Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi‐Ming Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi‐Ming Tu more than expected).
Fields of papers citing papers by Shi‐Ming Tu
This network shows the impact of papers produced by Shi‐Ming Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi‐Ming Tu. The network helps show where Shi‐Ming Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shi‐Ming Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 372 | |
| 2 | 2001 | 278 | |
| 3 | Establishment of two human prostate cancer cell lines derived from a single bone metastasis. | 1997 | 220 |
| 4 | 2002 | 193 | |
| 5 | 2007 | 144 | |
| 6 | 2009 | 139 | |
| 7 | 2002 | 137 | |
| 8 | 2019 | 121 | |
| 9 | 2001 | 116 | |
| 10 | 1986 | 104 | |
| 11 | 2002 | 92 | |
| 12 | 2016 | 78 | |
| 13 | 1995 | 74 | |
| 14 | 2007 | 69 | |
| 15 | 2007 | 68 | |
| 16 | 1992 | 66 | |
| 17 | Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer. | 1997 | 66 |
| 18 | 2009 | 62 | |
| 19 | 1995 | 61 | |
| 20 | 2011 | 59 |
About Shi‐Ming Tu
Shi‐Ming Tu is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Molecular Biology and Cancer Research, having authored 95 papers that have together received 3.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (22 papers), Testicular diseases and treatments (18 papers), Radiopharmaceutical Chemistry and Applications (9 papers), Bone health and treatments (8 papers), Cancer Genomics and Diagnostics (8 papers), Bladder and Urothelial Cancer Treatments (7 papers), Sarcoma Diagnosis and Treatment (7 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.4k citations), Oncology (1.1k citations), Cancer Research (449 citations), Surgery (900 citations) and Rheumatology (259 citations). Shi‐Ming Tu has collaborated with scholars based in United States, Spain and China. Frequent co-authors include Christopher J. Logothetis, Lance C. Pagliaro, Louis L. Pisters, Danai Daliani, Christos N. Papandreou, Nizar M. Tannir, Patricia Troncoso, Randall E. Millikan, Sue-Hwa Lin and Jeri Kim. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Clinical Genitourinary Cancer, Urologic Oncology Seminars and Original Investigations and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.